Laboratory standardization of a large international clinical trial: The DAIS experience

Clinical Biochemistry

Volumn 33, Issue 1, 2000, Pages 15-24

  McGuinness, Cathy ^a   Seccombe, David W ^a,b   Frohlich, Jiri J ^b,c   Ehnholm, Christian ^d   Sundvall, Jouko ^d   Steiner, George ^e  

^a Canadian Reference Laboratory   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Clinical trials; DAIS; Harmonization of standards; Laboratory standardization; Quality control

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; COMPUTER PROGRAM; LABORATORY; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CLINICAL CHEMISTRY TESTS; DOUBLE-BLIND METHOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LIPOPROTEINS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

EID: 0034021978     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00081-8     Document Type: Article

References (13)

1. Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group. Diabetologia 1996; 39: 1655-61.
2. Steiner G, Stewart D, Hosking JD, and the DAIS Project Group. The Diabetes Atherosclerosis Intervention Study (DAIS): baseline characteristics of the study population. Am J Cardiol 1999; 84: 1004-10.
3. McLaughlin P.R., Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS) quantitative coronary angiographic analysis of coronary artery atherosclerosis . Cathet Cardiovasc Diagn. 44:1988;249-256.
4. Camelon KM, Hådell K, Jamsèn PT, et al. for the DAIS Project Group. The plate model: a visual method of teaching meal planning. J Am Dietetic Assoc 1999; 98: 1155-8.
5. Desmet M., Linder S. The challenge of auditing clinical laboratories. Drug Info J. 31:1997;197-205.
6. Myers G.L., Cooper G.R., Henderson L.O., Hassemer D.J., Kimberly M.M. Standardization of lipid and liproptoein measurements. Warnick G.R., Dominiczak M.H. Handbook of lipoprotein testing Rfai. 1997;223-250 AACC Press, Washington, DC.
7. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low denisty lipoprotein cholesterol in plasma,without the use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
8. The Diabetes Control and Complications Trial research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-68.
9. Position statement of the CSCC and CAP Task Force on the measurement of lipids for the assessment of risk of CHD. Clin Biochem 1989; 22: 231-7.
10. Warnick G.R., Nguyen T., Albers A.A. Comparison of improved precipiation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 31:1985;217-222.
11. Davies C., Fahie-Wilson M.N. Use of magnesium acetate in high-density lipoprotein cholesterol assay. Clin Chem. 25:1979;1510.
12. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol detemination in high density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
13. Seigler L., Wu W.T. Separation of serum high-density lipoprotein for cholesterol determination ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride . Clin Chem. 27:1981;838-841.